Novartis Unit To Appeal German Laxative Ban

Law360 (February 7, 2008, 12:00 AM EST) -- Novartis AG subsidiary Hexal AG is planning to appeal a German court’s ruling banning the company from selling its laxative product containing macrogol, a company spokesman said Thursday.

The decision of the Hamburg District Court, which was revealed Monday by European pharmaceutical company Norgine Europe BV, ruled that Hexal and Cassella Med GbmH & Co. KG, a subsidiary of German health care conglomerate Klosterfrau Vertriebs GmbH, were illegally distributing their laxative products as medical devices, when they should have gained approval to market them as medicinal...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.